, in the current US pricing system, the price of the drug is the same regardless of the indication for which it is … high relative to the potential benefit for patients, which can reduce patients’ access to the drug. It can also deter the … drug manufacturer from investing in obtaining FDA approval for new indications, as the lack of flexibility in pricing can …

Background: Well-functioning competitive markets are key to controlling generic drug prices. This is important since …